Genetic dissociation of two behaviors associated with nicotine addiction: Beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome-Reference-Cited by-同舟云学术

Genetic dissociation of two behaviors associated with nicotine addiction: Beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome

Published:2006-06-03 Issue:2 Volume:187 Page:189-199
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Besson M.,David V.,Suarez S.,Cormier A.,Cazala P.,Changeux J.-P.,Granon S.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s00213-006-0418-z.pdf

Reference52 articles.

1. Aghajanian GK (1978) Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature 276:186–188

2. Aston-Jones G, Harris GC (2004) Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology 47:167–179

3. Barik J, Wonnacott S (2005) Indirect modulation by {alpha}7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal. Mol Pharmacol 69:618–628

4. Bozarth MA, Wise RA (1984) Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science 224:516–517

5. Castane A, Valjent E, Ledent C, Parmentier M, Maldonado R, Valverde O (2002) Lack of CB1 cannabinoid receptors modifies nicotine behavioral responses, but not nicotine abstinence. Neuropharmacology 43:857–867

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Treatment of Substance Use Disorders;Tasman’s Psychiatry;2024

2. Disorders Due to Substance Use: Nicotine;Tasman’s Psychiatry;2024

3. Impact of the gut microbiome on nicotine’s motivational effects and glial cells in the ventral tegmental area in male mice;Neuropsychopharmacology;2023-03-17

4. Pharmacological Treatment of Substance Use Disorders;Tasman’s Psychiatry;2023

5. Disorders Due to Substance Use: Nicotine (Including Tobacco and Vaping);Tasman’s Psychiatry;2023